PV

Pascal Voltzenlugel

Chief Executive Officer - Geschäftsführer

biosyn Arzneimittel GmbH

Basel, Basel-Stadt


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
biosyn Arzneimittel GmbH
Industry
pharmaceuticals
Employees
34.0
Seniority
C suite
Annual Revenue
14000000.0

Technologies

Outlook WordPress.org Mobile Friendly Bootstrap Framework Apache GoToWebinar Woo Commerce Google Font API reCAPTCHA Google Tag Manager Remote

Keywords

selenium hemocyanins dietary supplements pharmaceutical manufacturing selenase high-dose selenium injections medicinal products oral supplements injectable solutions sodium selenite pentahydrate trace elements nutritional deficiencies immune system support malnutrition thyroid health biotech gmp manufacturing pharmaceutical company health supplements zinc deficiency alimentary health clinical research pharmacovigilance medical devices biological agents chemical agents laboratory services patient-focused healthcare professionals nutritional support selenium supplementation infusion therapy product development therapeutic innovations international markets nutraceuticals science-based supplements healthcare nutrition wellness products food safety regulatory compliance cgmp production quality assurance biomedical research nutritional science vitamin d3 folic acid selenium products sporebiotics patient care medical applications burn treatment intensive care onco-immunology health wellness & fitness pharmaceuticals medical hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans